Anti-c-MET Nanobody®- a new potential drug in multiple myeloma treatment

Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy

(2012) M. J. W. D. Vosjan et al.   MOLECULAR CANCER THERAPEUTICS

MET: a promising anticancer therapeutic target

(2012) Solange Peters et al.   Nature Reviews Clinical Oncology

Impact of albumin on drug delivery — New applications on the horizon

(2011) Bakheet Elsadek et al.   JOURNAL OF CONTROLLED RELEASE

The effect of timing in the administration of hepatocyte growth factor to modulate BMP-2-induced osteoblast differentiation

(2009) Toshiki Kawasaki et al.   BIOMATERIALS

MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

(2008) H. Jin et al.   CANCER RESEARCH

Hepatocyte growth factor promotes migration of human myeloma cells

(2008) R. U. Holt et al.   HAEMATOLOGICA

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

(2008) B. M. Tijink et al.   MOLECULAR CANCER THERAPEUTICS

Single-domain antibody fragments with high conformational stability

(2002) Mireille Dumoulin et al.   PROTEIN SCIENCE